Last reviewed · How we verify
LY2140023 Reference form
At a glance
| Generic name | LY2140023 Reference form |
|---|---|
| Also known as | LY2140023 Monohydrate (Reference) |
| Sponsor | Denovo Biopharma LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LY2140023 Reference form CI brief — competitive landscape report
- LY2140023 Reference form updates RSS · CI watch RSS
- Denovo Biopharma LLC portfolio CI